Neuroethics

, Volume 2, Issue 3, pp 151–162 | Cite as

‘Cosmetic Neurology’ and the Moral Complicity Argument

  • A. Ravelingien
  • J. Braeckman
  • L. Crevits
  • D. De Ridder
  • E. Mortier
Original Paper

Abstract

Over the past decades, mood enhancement effects of various drugs and neuromodulation technologies have been proclaimed. If one day highly effective methods for significantly altering and elevating one’s mood are available, it is conceivable that the demand for them will be considerable. One urgent concern will then be what role physicians should play in providing such services. The concern can be extended from literature on controversial demands for aesthetic surgery. According to Margaret Little, physicians should be aware that certain aesthetic enhancement requests reflect immoral social norms and ideals. By granting such requests, she argues, doctors render themselves complicit to a collective ‘evil’. In this paper, we wish to question the extent to which physicians, psychiatrists and/or neurosurgeons should play a role as ‘moral gatekeepers’ in dealing with suspect demands and norms underlying potential desires to alter one’s mood or character. We investigate and discuss the nature and limits of physician responsibilities in reference to various hypothetical and intuitively problematic mood enhancement requests.

Keywords

Neuroenhancement Mood Doctors Moral responsibility Cosmetic surgery 

References

  1. 1.
    British Medical Association. 2007. Boosting your brainpower: ethical aspects of cognitive enhancements. Available from: http://www.bma.org.uk/ap.nsf/content/CognitiveEnhancement2007.
  2. 2.
    Chatterjee, A. 2006. The promise and predicament of cosmetic neurology. Journal of Medical Ethics 32(2): 110–113.CrossRefGoogle Scholar
  3. 3.
    Farah, M.J., J. Illes, R. Cook-Deegan, et al. 2004. Neurocognitive enhancement: what can we do and what should we do? Nature Reviews. Neuroscience 5(5): 421–425.CrossRefGoogle Scholar
  4. 4.
    Rose, S. 2006. Brain gain. In Better humans? The politics of human enhancement and life extension, ed. P. Miller, and J. Wilsdon, 69–79. London: Demos.Google Scholar
  5. 5.
    Greely, H., B. Sahakian, J. Harris, et al. 2008. Towards responsible use of cognitive-enhancng drugs by the healthy. Nature 456(7223): 702–705.CrossRefGoogle Scholar
  6. 6.
    Little, M.O. 1998. Cosmetic surgery, suspect norms, and the ethics of complicity. In Enhancing human traits: ethical and social implications, ed. E. Parens, 162–177. Washington, D.C.: Georgetown University Press.Google Scholar
  7. 7.
    Chatterjee, A. 2004. Cosmetic neurology: the controversy over enhancing movement, mentation, and mood. Neurology 63(6): 968–974.Google Scholar
  8. 8.
    Hughes, J. 2007. The struggle for a smarter world. Futures 39(8): 942–954.CrossRefGoogle Scholar
  9. 9.
    Mc Carthy, M. 2007. Prescription drug abuse up sharply in the USA. Lancet 369(9572): 1505–1506.CrossRefGoogle Scholar
  10. 10.
    Tindall B. 2004. Better playing through chemistry. The New York Times, Oct 17, 2004. Available from: http://www.nytimes.com/2004/10/17/arts/music/17tind.html?pagewanted=all&position=.
  11. 11.
    Tse, W.S., and A.J. Bond. 2002. Serotonergic intervention affects both social dominance and affiliative behaviour. Psychopharmacology 161(3): 324–330.CrossRefGoogle Scholar
  12. 12.
    Kramer, P. 1993. Listening to Prozac. New York: Penguin.Google Scholar
  13. 13.
    Elliott, C. 2007. Against happiness. Medicine, Health Care and Philosophy 10(2): 167–171.CrossRefGoogle Scholar
  14. 14.
    Kirsch, I., B.J. Deacon, T.B. Huedo-Medina, et al. 2008. Initial severity and antidepressant benefits: A meta-analysis of data submitted to the Food and Drug Administration. PLOS Medicine 5(2): e45.CrossRefGoogle Scholar
  15. 15.
    Lippold, O.C., and J.W. Redfearn. 1964. Mental changes resulting from the passage of small direct currents through the human brain. British Journal of Psychiatry 110: 768–772.CrossRefGoogle Scholar
  16. 16.
    George, M.S., E.M. Wassermann, and R.M. Post. 1996. Transcranial magnetic stimulation: a neuropsychiatric tool for the 21st century. Journal of Neuropsychiatry and Clinical Neurosciences 8(4): 373–382.Google Scholar
  17. 17.
    Mosimann, U.P., T.A. Rihs, J. Engeler, et al. 2000. Mood effects of repetitive transcranial magnetic stimulation of left prefrontal cortex in healthy volunteers. Psychiatry Research 94(3): 251–256.CrossRefGoogle Scholar
  18. 18.
    Jenkins, J., P.M. Shajahan, J.M. Lappin, et al. 2002. Right and left prefrontal transcranial magnetic stimulation at 1 Hz does not affect mood in healthy volunteers. BMC Psychiatry 2: 1.CrossRefGoogle Scholar
  19. 19.
    Pascual-Leone, A., M.D. Catalá, and P.A. Pascual-Leone. 1996. Lateralized effect of rapid-rate transcranial magnetic stimulation of the prefrontal cortex on mood. Neurology 46(2): 499–502.Google Scholar
  20. 20.
    Gruzelier, J., T. Egner, and D. Vernon. 2006. Validating the efficacy of neurofeedback for optimising performance. Progress in Brain Research 159: 421–431.CrossRefGoogle Scholar
  21. 21.
    Delgado, J. 1969. Toward a psychocivilized society. New York: Harper and Row.Google Scholar
  22. 22.
    Heath, R.G. 1972. Pleasure and brain activity in man. Deep and surface electroencephalograms during orgasm. Journal of Nervous and Mental Disease 154(1): 3–18.CrossRefGoogle Scholar
  23. 23.
    Okun, M.S., J. Green, R. Saben, et al. 2003. Mood changes with deep brain stimulation of STN and GPi: results of a pilot study. Journal of Neurology, Neurosurgery and Psychiatry 74(11): 1584–1586.CrossRefGoogle Scholar
  24. 24.
    De Ridder, D., G. De Mulder, V. Walsh, et al. 2004. Magnetic and electrical stimulation of the auditory cortex for intractable tinnitus. Case report. Journal of Neurosurgery 100(3): 560–564.CrossRefGoogle Scholar
  25. 25.
    Thimineur, M., and D. De Ridder. 2007. C2 area neurostimulation: a surgical treatment for fibromyalgia. Pain Medicine 8(8): 639–646.CrossRefGoogle Scholar
  26. 26.
    Nahas, Z., L.B. Marangell, M.M. Husain, et al. 2005. Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. Journal of Clinical Psychiatry 66(9): 1097–1104.CrossRefGoogle Scholar
  27. 27.
    Lind, G., G. Schechtmann, and B. Linderoth. 2007. Drug-enhanced spinal stimulation for pain: a new strategy. Acta Neurochirurgica. Supplementum 97(Pt 1): 57–63.Google Scholar
  28. 28.
    Terney, D., I. Bergmann, C. Poreisz, et al. 2008. Pergolide increases the efficacy of cathodal direct current stimulation to reduce the amplitude of laser-evoked potentials in humans. Journal of Pain and Symptom Management 36(1): 79–91.CrossRefGoogle Scholar
  29. 29.
    Chatterjee, A. 2007. Cosmetic neurology and cosmetic surgery: parallels, predictions, and challenges. Cambridge Quarterly of Healthcare Ethics 16(2): 129–137.CrossRefGoogle Scholar
  30. 30.
    Elliott C. Date unknown. Medicate your dissent. Available from: http://www.tc.umn.edu/~ellio023/medicate.htm (cited 2008 April 10).
  31. 31.
    Anonymous. 2006. Testosterone offers women benefits, risks. Iconocast [serial on the Internet]. Available from: http://www.iconocast.com/News_Files/HNews6_27_06/Health9A.htm (cited 2008 Febr 27).
  32. 32.
    Anonymous. Date unknown. Editorial review: O’Neill BE. The testosterone edge: The breakthrough plan to boost energy, fight disease, improve mood, and increase sexual vitality. Available from: http://www.amazon.com/Testosterone-Edge-Breakthrough-Increase-Vitality/dp/1578261961 (cited 2008 Febr 27).
  33. 33.
    Hyman, S.E. 2006. Improving our brains? BioSocieties 1: 103–111.CrossRefGoogle Scholar
  34. 34.
    Ontorio Consultants on Religious Tolerance. Date unknown. Reparative and similar therapies: Introduction. Available from: http://www.religioustolerance.org/hom_exod.htm (cited 2008 Febr 27).
  35. 35.
    Riis, J., J.P. Simmons, and G.P. Goodwin. 2008. Preferences for enhancement pharmaceuticals: the reluctance to enhance fundamental traits. Journal of Consumer Research 35(3): 495–508.CrossRefGoogle Scholar
  36. 36.
    Gupta, S. 2003. Ethnic makeover. Time 162(14): 88.Google Scholar
  37. 37.
    Pellegrino, E.D. 2005. Some things ought never be done: moral absolutes in clinical ethics. Theoretical Medicine 26(6): 469–486.CrossRefGoogle Scholar
  38. 38.
    Relman, A.S. 2007. The problem of commercialism in medicine. Cambridge Quarterly of Healthcare Ethics 16(4): 375–376. discussion 439–42.CrossRefGoogle Scholar
  39. 39.
    Engel, J.L. 1977. The need for a new medical model: a challenge for biomedicine. Science 196: 129–136.CrossRefGoogle Scholar
  40. 40.
    Goosens, W.K. 1980. Values, health and medicine. Philosophy in Science 47: 100–115.CrossRefGoogle Scholar
  41. 41.
    Savulescu, J. 2006. Justice, fairness, and enhancement. Annals of the New York Academy of Sciences 1093: 321–328.CrossRefGoogle Scholar
  42. 42.
    Sclafani, A.P. 2007. Understanding physician responsibilities and limitations for drug and device off-label use. Facial Plastic Surgery Clinics of North America 15(2): 251–254. viii.CrossRefGoogle Scholar
  43. 43.
    International Society of Aesthetic Plastic Surgery. ISAPS Ethics [homepage on the Internet]. Available from: http://www.isaps.org/ethics.php (cited 2008 March 21).
  44. 44.
    Glannon, W. 2007. Bioethics and the brain. New York: Oxford University Press.Google Scholar
  45. 45.
    President’s Council on Bioethics. 2003. Beyond therapy: Biotechnology and the pursuit of happiness [monograph on the internet]. Available from: http://www.bioethics.gov/reports/beyondtherapy/beyond_therapy_final_webcorrected.pdf (cited 2008 March 10).
  46. 46.
    Wijsbek, H. 2000. The pursuit of beauty: the enforcement of aesthetics or a freely adopted lifestyle? Journal of Medical Ethics 26(6): 454–458.CrossRefGoogle Scholar
  47. 47.
    Bush, S.S. 2006. Neurocognitive enhancement: ethical considerations for an emerging subspecialty. Applied Neuropsychology 13(2): 125–136.CrossRefGoogle Scholar
  48. 48.
    American Medical Association. 2000. Declaration of professional responsibility. Appendix in: Council on ethical and judicial affairs. Code of medical ethics -current opinions, 2000–2001 Edition, xiv. Chicago: American Medical Association.Google Scholar
  49. 49.
    Ravelingien, A., and A. Sandberg. 2008. Sleep better than medicine? Ethical issues related to ‘wake enhancement’. Journal of Medical Ethics 34: e9.CrossRefGoogle Scholar
  50. 50.
    Kutz, C. 2000. Complicity: ethics and law for a collective age. Cambridge: Cambridge University Press.Google Scholar
  51. 51.
    Brock, D.W. 2008. Conscientious refusal by physicians and pharmacists. Who is obligated to do what and why? Theoretical Medicine 29: 187–200.CrossRefGoogle Scholar
  52. 52.
    Wicclair, R.M. 2000. Conscientious objection in medicine. Bioethics 14(3): 205–227.CrossRefGoogle Scholar
  53. 53.
    Veatch, R. 2005. Disrupted dialogue: medical ethics and the collapse of physician-humanist communication. New York: Oxford University Press.Google Scholar
  54. 54.
    Shirrat, G.M., and R. Gill. 2005. Autonomy in medical ethics after O’Neill. Journal of Medical Ethics 31: 127–130.CrossRefGoogle Scholar
  55. 55.
    Atkins, K. 2000. Autonomy and the subjective character of experience. Journal of Applied Philosophy 17(1): 71–79.CrossRefGoogle Scholar
  56. 56.
    Draper, H., and T. Sorell. 2002. Patients’ responsibilities in medical ethics. Bioethics 16(4): 335–352.CrossRefGoogle Scholar
  57. 57.
    O’Neill, O. 2003. Some limits of informed consent. Journal of Medical Ethics 29: 4–7.CrossRefGoogle Scholar
  58. 58.
    Elliott, C. 2000. Pursued by happiness and beaten senseless. Prozac and the American dream. Hastings Center Report 30(2): 7–12.CrossRefGoogle Scholar
  59. 59.
    Lexchin, J. 2001. Lifestyle drugs: issues for debate. Canadian Medical Association Journal 164: 1449–1451.Google Scholar

Copyright information

© Springer Science+Business Media B.V. 2009

Authors and Affiliations

  • A. Ravelingien
    • 1
  • J. Braeckman
    • 1
  • L. Crevits
    • 2
  • D. De Ridder
    • 3
  • E. Mortier
    • 4
  1. 1.Department of Philosophy, Bioethics Institute GhentGhent UniversityGentBelgium
  2. 2.Department of NeurologyGhent University HospitalGentBelgium
  3. 3.BRAI2N & Department of NeurosurgeryUniversity of Antwerp HospitalEdegemBelgium
  4. 4.Department of AnaesthesiologyGhent University HospitalGentBelgium

Personalised recommendations